SCHEMBL6871011

SCHEMBL6871011

CC1(C)[C@]2(O)[C@@](C)(CO)O[C@@H](n3cnc4c(N)ncnc43)[C@]12O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.57
▸ PI4K2A Q9BTU6 3/20 0.53
▸ PI4KA P42356 2/20 0.53
▸ PI4K2B Q8TCG2 2/20 0.53
▸ PI4KB Q9UBF8 2/20 0.53
▸ ADORA3 P0DMS8 6/20 0.48
▸ AHCY P23526 5/20 0.45
▸ SLC28A1 O00337 2/20 0.45
▸ SLC28A2 O43868 2/20 0.45
▸ DPP4 P27487 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ MAP3K7 O43318 1/20 0.45
▸ GAPDH P04406 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ STAT6 P42226 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ DOT1L Q8TEK3 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6298535 0.84 ADORA2A (0.53) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL28156591 0.76 ADORA2A (0.64) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL1078828 0.76 ADORA2A (0.64) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL19859805 0.75 ADORA2A (0.62) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL22474991 0.74 ADORA2A (0.64) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL19692161 0.74 ADORA2A (0.58) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL11040343 0.74 ADORA2A (0.58) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL8672664 0.74 ADORA2A (0.67) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL8943715 0.73 ADORA2A (0.57) ADORA2API4K2API4KAPI4K2BPI4KB
SCHEMBL19859736 0.73 ADORA2A (0.57) ADORA2API4K2API4KAPI4K2BPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6822089-B1 FROM CORRESPONDING RIBONUCLEOSIDES BY FORMING 3-TERT-BUTYLPHENOXYTHIOCARBONYL DERIVATIVES AND EFFECTING RADICAL DEOXYGENATION; SOLID PHASE SYNTHESIS ISIS PHARMACEUTICALS, INC. 2004-11-23 — — US disclosed
EP-1366056-A2 PREPARATION OF DEOXYNUCLEOSIDES ISIS PHARMACEUTICALS, INC. (US) 2003-12-03 — — EP disclosed
EP-1366056-A4 PREPARATION OF DEOXYNUCLEOSIDES ISIS PHARMACEUTICALS INC (US) 2003-12-03 — — EP disclosed
WO-2001073095-A2 PREPARATION OF DEOXYNUCLEOSIDES ISIS PHARMACEUTICALS, INC. (US) 2001-10-04 — — WO disclosed
Send feedback